SHINE Opens New Facility
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
Exact Sciences plans to submit next-generation Cologuard tests for FDA approval, the company announced recently. According to a release, the results from its BLUE-C study saw 94 percent sensitivity for…
Phoenix has increased its capacity for neutron imaging this year by 20%, the company announced today. According to a release, the upcoming closing of GE Hitachi’s Vallecitos Nuclear Center in…
SHINE Technologies is now offering state-of-the-art radiation effects testing, the company announced today. According to a release, the service, called FLARE (Fusion Linear Accelerator for Radiation Effects), will use high-energy…
The Wisconsin Alumni Research Foundation (WARF) has partnered with Boston-based Ginkgo Bioworks to discover next-generation GD2 CAR T-cell therapies, the organization announced today. According to a release, CAR T-cell therapies…
Type One Energy has closed on a $29 million financing round, the organization announced today. According to a release, the funding was co-led by Breakthrough Energy Ventures (BEV), TDK Ventures…
NorthStar Medical Radioisotopes has received a custom-built IBA Rhodotron TT 300-HR electron beam accelerator to its new Ac-225 Production facility, the organization announced recently. According to a release, the accelerator…
Promega announced recently that it has launched a wastewater testing kit that pairs its Maxwell HT chemistry with Ceres Nanosciences’ Nanotrap particles, an established technology for capturing and concentrating low-abundance…
JangoCell, a subsidiary of JangoBio, has entered into a distribution partnership for Captivate Bio’s culture media, balanced salt solutions, small molecules and other culture reagents, the company announced recently. “JangoCell…
Nimble Therapeutics has expanded its collaboration and executed a license agreement with Genentech, the company announced recently. According to a release, the two companies will work together on the discovery…